Microbiome-targeted Therapy
Microbiome-Targeted Therapy is a therapeutic strategy that modulates the composition or function of the gastrointestinal microbiota to prevent or treat diarrheal diseases through the selective alteration of microbial communities.
333
Publications
26K
Citations
2.5K
Authors
890
Institutions
Publications per year
2017–2026
287
Parents
333
Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
Diwakar Davar, Amiran Dzutsev, John A. McCulloch et al. · Science · 2021 · 1.6K citations · Full text
Life Sciences, Immunology, Oncology +17
1–5 of 333
2.5K
7
h-index
6
h-index
6
h-index
5
h-index
Second Affiliated Hospital of Nanjing Medical University, China
5 publications · 394 citations
5
h-index
1–5 of 2.5K
890
Harvard University
Cambridge, United States
14 h-index
27 publications
2.8K citations

Imperial College London
London, United Kingdom
11 h-index
39 publications
4.3K citations
Massachusetts General Hospital
Boston, United States
10 h-index
33 publications
1.7K citations
Inserm
Paris, France
9 h-index
36 publications
1.8K citations
Chinese University of Hong Kong
Hong Kong, Hong Kong
8 h-index
52 publications
1.9K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
8 h-index
48 publications
17.9K citations
University of California, San Francisco
San Francisco, United States
7 h-index
29 publications
2K citations

The University of Melbourne
Melbourne, Australia
7 h-index
8 publications
1.7K citations
1–8 of 890
17 publications · 1.3K citations
14
h-index
9 publications · 704 citations
9
h-index
7 publications · 497 citations
7
h-index
Repository · 5 publications · 184 citations
5
h-index
5 publications · 327 citations
5
h-index
1–5